A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
about
State-of-the-Art management of knee osteoarthritisGlucosamine and N-acetyl glucosamine as new CEST MRI agents for molecular imaging of tumorsWho uses glucosamine and why? A study of 266,848 Australians aged 45 years and olderThe human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.Knee osteoarthritis related pain: a narrative review of diagnosis and treatment.Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosisClinical validity of outcome pain measures in naturally occurring canine osteoarthritisEfficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic reviewTeriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations.MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.The anti-arthritic and immune-modulatory effects of NHAG: a novel glucosamine analogue in adjuvant-induced arthritis.Knee osteoarthritis diagnosis, treatment and associated factors of progression: part II.Mind the gaps! Clinical and technical aspects of PCL-retaining total knee replacement with the balanced gap technique: an academic essay in Medical Science.Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations.[Conservative therapy of osteoarthritis].Effect of Glucosamine Sulfate on Osteoarthritis in the Cruciate-Deficient Canine Model of Osteoarthritis.Symptomatic Early Osteoarthritis of the Knee Treated With Pulsed Electromagnetic Fields: Two-Year Follow-upGlucosamine and chondroitin for the treatment of osteoarthritis.Inhibition by chondroitin sulfate E can specify functional Wnt/β-catenin signaling thresholds in NIH3T3 fibroblasts.Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique.Effects of anti-aggregant, anti-inflammatory and anti-coagulant drug consumption on the preparation and therapeutic potential of plasma rich in growth factors (PRGF).Comparison of the effects of exercise with chondroitin sulfate on knee osteoarthritis in rabbits.Targeting the gut microbiome to treat the osteoarthritis of obesity.
P2860
Q26859086-BB1A560E-EFE3-4AA6-9628-2B8D182DB7AFQ28831190-83A506F8-35B2-4A84-A381-257EFC62B3B5Q31080416-A0EFB092-CCE2-4A1D-97E2-10715A7B8275Q33679221-57C1199A-2603-4BE5-B98D-E5569A4554FAQ33690451-5861DDBB-C95E-4E52-B3A4-71B7888E8609Q34069452-B842E4ED-0099-4356-A606-E2CBE17C9CF5Q34410470-9218C57B-85F3-475B-9CF3-17E5E80CF9B9Q34605351-91C5047B-EFA2-4542-BC95-454F8B830ABEQ35525309-B28ABEF8-4B3A-4104-B62A-6F25FAA491CAQ36059429-6D384898-22F3-4EC6-9A11-FDB4194A806FQ36983759-EDF709EA-C7CD-479F-89C7-F50EA1385B72Q37067708-367EBC92-ABA1-4256-A1CB-3E95E5436CD4Q37164156-0D0C45F7-49D6-4D2E-9104-DAD5C3E5C191Q37944857-B88DB92C-5FAC-45F2-B3E2-79037F75E63FQ37960179-CCA2071A-1C51-4130-8EF6-14234F67B563Q39233201-6E872723-4941-4D2E-BAA4-7ACDC2A480F2Q41636872-F1D83857-701E-44AD-B7A6-3170A90C9563Q42151551-A9B875D4-D98C-4927-8418-8D6261B808F6Q42330053-975C5031-98CD-4A2B-A5A0-1996DABF3296Q42404046-4AE3A1CF-3F17-43B8-B325-605EBE7B4199Q44118071-4FAADE1A-6E54-4A6E-B865-DE949A7A636CQ48818751-E05C9A42-E376-4182-9D62-89F266FFA0ADQ49393288-F0941B80-CC90-4DF7-93F5-8BDA9FF1AC13Q52579668-65CF6235-0AD6-42CB-B87D-ABDE149C24B0
P2860
A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A review of evidence-based med ...... te use in knee osteoarthritis.
@ast
A review of evidence-based med ...... te use in knee osteoarthritis.
@en
A review of evidence-based med ...... te use in knee osteoarthritis.
@nl
type
label
A review of evidence-based med ...... te use in knee osteoarthritis.
@ast
A review of evidence-based med ...... te use in knee osteoarthritis.
@en
A review of evidence-based med ...... te use in knee osteoarthritis.
@nl
prefLabel
A review of evidence-based med ...... te use in knee osteoarthritis.
@ast
A review of evidence-based med ...... te use in knee osteoarthritis.
@en
A review of evidence-based med ...... te use in knee osteoarthritis.
@nl
P2093
P1433
P1476
A review of evidence-based med ...... te use in knee osteoarthritis.
@en
P2093
C Thomas Vangsness
Juliana Erickson
William Spiker
P356
10.1016/J.ARTHRO.2008.07.020
P577
2008-09-30T00:00:00Z